Public Citizen Expert Says FDA Draft Guidance Would Let Pharmaceutical Industry Tell Doctors Medications Are Safer Than They Really Are
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) recently issued draft guidance that would let the pharmaceutical industry essentially circumvent drug labeling rules and tell doctors that its products have fewer risks than those described in the FDA-approved labeling. This is discussed by Dr. Sidney Wolfe, founder and senior adviser of Public Citizen’s Health Research Group, in a Journal of the American Medical Association (JAMA) Internal Medicine article.